ATC Group: B01AC13 Abciximab

Anatomical Therapeutic Chemical Classification System

Translations

Language
Translation
  English
Abciximab

Hierarchical Position

Active Ingredients

Chemical substance
Description

Abciximab is the Fab fragment of the chimeric monoclonal antibody 7E3. It is directed against the glycoprotein (GP) IIb/IIIa (╬▒IIb╬▓3) receptor located on the surface of human platelets. Abciximab inhibits platelet aggregation by preventing the binding of fibrinogen, von Willebrand factor, and other adhesive molecules to GPIIb/IIIa receptor sites on activated platelets.